A carregar...
The Pharmacology, Efficacy, and Safety of Rivaroxaban in Obese Patient Populations
Cardiovascular disease (CVD) remains the leading cause of death in the USA. Several risk factors have been identified, and obesity has become one of prominent concern. Excessive weight is considered a risk factor for CVD based on evidence linking it to a hypercoagulable state. Considering the preval...
Na minha lista:
| Publicado no: | Am J Cardiovasc Drugs |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8089078/ https://ncbi.nlm.nih.gov/pubmed/32803514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40256-020-00434-w |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|